Brief: Addex Therapeutics Starts Phase 2 Clinical Study With Dipraglurant
29/09/2021 06:06
Sept 29 (Reuters) - ADDEX THERAPEUTICS LTD ADXN.S :
* ADDEX THERAPEUTICS INITIATES PHASE 2 CLINICAL STUDY WITH
DIPRAGLURANT IN BLEPHAROSPASM
* DATA FROM STUDY ARE EXPECTED IN Q1 2022
Source text for Eikon: ID:nGNE88mQx5
Further company coverage: ADXN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))